Εμφανίζονται 1 - 6 Αποτελέσματα από 6 για την αναζήτηση '"лёгочная эндартерэктомия"', χρόνος αναζήτησης: 0,64δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συνεισφορές: 0

    Πηγή: Annals of the Russian academy of medical sciences; Vol 78, No 4 (2023); 297-304 ; Вестник Российской академии медицинских наук; Vol 78, No 4 (2023); 297-304 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.784

    Περιγραφή αρχείου: application/pdf

  2. 2
    Academic Journal

    Πηγή: PULMONOLOGIYA; Том 31, № 3 (2021); 304-310 ; Пульмонология; Том 31, № 3 (2021); 304-310 ; 2541-9617 ; 0869-0189

    Περιγραφή αρχείου: application/pdf

    Relation: https://journal.pulmonology.ru/pulm/article/view/2366/1840; Авдеев С.Н., Царева Н.А., Мержоева З.М. и др. Практические рекомендации по кислородотерапии и респираторной поддержке пациентов с COVID-19 на дореанимационном этапе. Пульмонология. 2020; 30 (2): 151–163. DOI:10.18093/0869-0189-2020-30-2-151-163.; World Health Organization. Coronavirus Disease 2019 (COVID-19). Situation Report – 189. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200727-covid-19-sitrep-189.pdf?sfvrsn=b93a6913_2 [Accessed: July 27, 2020].; Министерство здравоохранения Российской Федерации. Временные методические рекомендации: Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 9 (26.10.2020). Доступно на: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/052/548/original/%D0%9C%D0%A0_COVID-19_%28v.9%29.pdf?1603730062 [Дата обращения: 20.11.20].; Бубнова М.Г., Аронов Д.М. COVID-19 и сердечно-сосудистые заболевания: от эпидемиологии до реабилитации. Пульмонология. 2020; 30 (5): 688–699. DOI:10.18093/0869-0189-2020-30-5-688-699.; Nuche J., Segura de la Cal T., Jiménez López Guarch C. et al. Effect of coronavirus disease 2019 in pulmonary circulation. The particular scenario of precapillary pulmonary hypertension. Diagnostics. 2020; 10 (8): 548. DOI:10.3390/diagnostics10080548.; Driggin E., Madhavan M.V., Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J. Am. Coll. Cardiol. 2020; 75 (18): 2352–2371. DOI:10.1016/j.jacc.2020.03.031.; Guo T., Fan Y., Chen M. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020; 5 (7): 811–818. DOI:10.1001/jamacardio.2020.1017.; Danzi G.B., Loffi M., Galeazzi G., Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur. Heart J. 2020; 41 (19): 1858. DOI:10.1093/eurheartj/ehaa254.; Magrone T., Magrone M., Jirillo E. Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target – a perspective. Endocr. Metab. Immune Disord. Drug Targets. 2020; 20 (6): 807–811. DOI:10.2174/1871530320666200427112902.; Humbert M., Guignabert C., Bonnet S. et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur. Respir. J. 2019; 53 (1): 1801887. DOI:10.1183/13993003.01887-2018.; Harder E.M., Small A.M., Fares W.H. Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014. Respir. Med. 2020; 161: 105850. DOI:10.1016/j.rmed.2019.105850.; Чазова И.Е., Мартынюк Т.В. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (II часть). Терапевтический архив. 2016; 88 (10): 63–73. DOI:10.17116/terarkh201688663-73.; Galie N., Humbert M., Vachiery J.L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur. Respir. J. 2015; 46 (6): 1855–1856. DOI:10.1183/13993003.51032-2015.; Horn E.M., Chakinala M., Oudiz R. et al. Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19? Pulm. Circ. 2020; 10 (2): 2045894020922799. DOI:10.1177/2045894020922799.; Segura de la Cal T., Nuche J., Jiménez López-Guarch C. et al. Unexpected favourable course of Coronavirus Disease 2019 in chronic thromboembolic pulmonary hypertension patients. Arch. Bronconeumol. 2020; 56 (11): 749–752. DOI:10.1016/j.arbres.2020.06.004 (in English, Spanish).; Sardu C., Gambardella J., Morelli M.B. et al. Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J. Clin. Med. 2020; 9 (5): 1417. DOI:10.3390/jcm9051417.; Smeda M., Chlopicki S. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter? Cardiovasc. Res. 2020; 116 (10): e118–121. DOI:10.1093/cvr/cvaa190.; Xiong T.Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur. Heart J. 2020; 41 (19): 1798–1800. DOI:10.1093/eurheartj/ehaa231.; Cooper L.T. Jr. Myocarditis. N. Engl. J. Med. 2009; 360 (15): 1526-1538. DOI:10.1056/NEJMra0800028.; Levy J., Léotard A., Lawrence C. et al. A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments following severe COVID-19. Ann. Phys. Rehabil. Med. 2020; 63 (4): 376–378. DOI:10.1016/j.rehab.2020.04.002.; Yang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020; 8 (5): 475–481. DOI:10.1016/S2213-2600(20)30079-5.; Carfì A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324 (6): 603–605. DOI:10.1001/jama.2020.12603.; Mo X., Jian W., Su Z. et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020; 55 (6): 2001217. DOI:10.1183/13993003.01217-2020.; Patelli G., Paganoni S., Besana F. et al. Preliminary detection of lung hypoperfusion in discharged COVID-19 patients during recovery. Eur. J. Radiol. 2020; 129: 109121. DOI:10.1016/j.ejrad.2020.109121.; Becker R.C. COVID-19 update: COVID-19-associated coagulopathy. J. Thrombosis Thrombolysis. 2020; 50 (1): 54–67. DOI:10.1007/s11239-020-02134-3.; https://journal.pulmonology.ru/pulm/article/view/2366

  3. 3
    Academic Journal

    Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 36, № 3 (2021); 154-160 ; Сибирский журнал клинической и экспериментальной медицины; Том 36, № 3 (2021); 154-160 ; 2713-265X ; 2713-2927

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/1258/651; Konstantinides S.V., Torbicki A., Agnelli G., Danchin N., Fitzmaurice D., Galie` N. et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur. Heart J. 2014;35(43):3033–3080. DOI:10.1093/eurheartj/ehu283.; Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.-J., Harjola V.-P., Huisman M.V. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2020;41(4):543–603. DOI:10.1093/eurheartj/ehz405.; Васильцева О.Я., Ворожцова И.Н., Карпов Р.С. Многогранность факторов риска венозной тромбоэмболии. Врач. 2014;8:5–9.; Galie` N., Humbert M., Vachieryc J.-L., Gibbs S., Lang I., Torbicki A. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 2016;37(1)1:67–119. DOI:10.1093/eurheartj/ehv317.; Мордовин В.Ф., Пекарский С.Е., Семке Г.В., Рипп Т.М., Фальковская А.Ю., Ситкова Е.С. и др. Использование современных медицинских технологий для диагностики и лечения больных артериальной гипертонией. Сибирский журнал клинической и экспериментальной медицины. 2015;30(2):29–35. DOI:10.29001/2073-8552-2015-30-229-35.; Чазова И.Е., Мартынюк Т.В., Валиева З.С., Азизов В.А., Акчурин Р.С., Аншелес А.А. и др. Евразийские рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (2020). Евразийский кардиологический журнал. 2021;(1):6–43. DOI:10.38109/2225-1685-2021-1-6-43.; Едемский А.Г., Иванов С.Н., Кливер Е.Н., Новикова Н.В., Галстян М.Г., Севастьянов В.В. и др. Путь пациента от острой тромбоэмболии легочной артерии до хронической тромбоэмболической легочной гипертензии: вопросы диагностики и лечения. Терапевтический архив. 2019;91(8):108–114. DOI:10.26442/00403660.2019.08.000316.; Венгеровский А.И. Фармакология: учебник. М.: ГЭОТАР-Медиа; 2020:848.; https://www.sibjcem.ru/jour/article/view/1258

  4. 4
  5. 5
  6. 6
    Academic Journal

    Πηγή: Aterotromboz = Atherothrombosis; № 2 (2014); 70-81 ; Атеротромбоз; № 2 (2014); 70-81 ; 2658-5952 ; 2307-1109 ; 10.21518/2307-1109-2014-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.aterotromboz.ru/jour/article/view/38/64; VTE Impact Assessment Group in Europe. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost, 2007, 98: 756-764.; 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. European Heart Journal. doi:10.1093/eurheartj/ehu283.; Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest, 1982, Feb., 81 (2): 151-8.; Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension. A Scientific Statement From the American Heart Association. Circulation, 2011, 123: 1788-1830.; Presti B, Berthrong M, Sherwin RM. Chronic thrombosis of major pulmonary arteries. Hum Pathol., 1990, 21: 601-606.; Lang IM. Chronic thromboembolic pulmonary hypertension: not so rare after all. NEnglJMed., 2004, 350: 2236-2238.; McNeil K1, Dunning J. Chronic thromboembolic pulmonary hypertension (CTEPH). Heart, 2007, Sep., 93 (9): 1152-8.; Воробьева Н.М., Панченко Е.П. Новые пероральные антикоагулянты и ацетилсалициловая кислота в лечении венозных тромбоэмболических осложнений. Атеротромбоз, 2013, 1: 53-65.; Kearon C. Natural history of venous thromboembolism. Circulation, 2003, Jun. 17, 107 (23 Suppl. 1): I22-30.; Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология, 2010, 1 (2).; Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST, 2012,141 (2 (Suppl.)): e419S-e494S.; Goldhaber SZ, Piazza G. Optimal duration of anticoa-gulation after venous thromboembolism. Circulation, 2011, Feb. 15, 123 (6): 664-7.; Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. European Genetics foundation; Cardiovascular Disease Educational and Research Trust; International Union of Angiology;Mediterranean League on Thromboembolism. IntAngiol., 2005, Mar., 24 (1): 1-26.; Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic throm-boembolic pulmonary hypertension: results from an international prospective registry.J Thorac Cardiovasc Surg, 2011, 141 (3): 702-710.; R. Cervera Update on the Diagnosis, Treatment, and Prognosis of the Catastrophic Antiphospholipid Syndrome. Curr Rheumatol Rep, 2010, 12: 70-76.; Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, Fedullo PF, Jamieson SW. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Погас Surg, 2012, 94 (1): 97-103.; Mayer E, Jenkins D, Lindner J, D'Armini A, Kloek J, Meyns B, Ilkjaer LB, KlepetkoW, Delcroix M, Lang I, Pepke-Zaba J, Simonneau G, Dartevelle P. Surgical management and outcome of patients; with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.J Thorac Cardiovasc Surg, 2011, 141 (3): 702-710.; Jenkins DP, Madani M, Mayer E, Kerr K, Kim N, Klepetko W, Morsolini M, Dartevelle P. Surgical treatment of chronic thromboembolic pulmonary hyper-tension.EurRespirJ, 2013,41 (3): 735-742.; Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, Kapelanski DP, Watt CN, Moser KM. Long-term outcome after pulmonary thromboen-darterectomy. Am J Respir Crit Care Med., 1999, 160: 523-528.; Yoshimi S, Tanabe N, Masuda M, Sakao S, Uruma T, Shimizu H, Kasahara Y, Takiguchi Y, Tatsumi K, Nakajima N, Kuriyama T. Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension. CircJ., 2008, 72: 958-965.; Corsico AG, D'Armini AM, Cerveri I, Klersy C, Ansaldo E, Niniano R, Gatto E, Monterosso C, Morsolini M, Nicolardi S, Tramontin C, Pozzi E, Vigano" M. Long-term outcome after pulmonary endarterectomy. AmJRespirCritCareMed., 2008, 178:419-424.; https://www.aterotromboz.ru/jour/article/view/38